Cogent Biosciences Inc (COGT) — Cash Flow Reinvestment Rate

Latest as of December 2015: 0.11x

Cogent Biosciences Inc (COGT) has a Cash Flow Reinvestment Rate of 0.11x as of December 2015, reinvesting $1.99 Million (capex $1.99 Million ) from operating cash flow of $17.72 Million. See COGT cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.

Reinvestment Rate

0.11x
(Capex + Investments) / Operating CF

Total Reinvested

$1.99 Million
Capex + Investments

Operating Cash Flow

$17.72 Million
USD

Capital Expenditures

$1.99 Million
USD

Cogent Biosciences Inc Cash Flow Reinvestment Rate (2015–2015)

Historical reinvestment intensity for Cogent Biosciences Inc across 1 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of Cogent Biosciences Inc.

Annual Cash Flow Reinvestment Rate for Cogent Biosciences Inc (2015–2015)

Year-by-year capital reinvestment analysis for Cogent Biosciences Inc. See COGT FCF to total liabilities ratio to measure the company's free cash flow as a share of total liabilities.

Year Reinvestment Rate Total Reinvested (USD) Operating CF Capex YoY Change
2015 0.11x $1.99 Million $17.72 Million $1.99 Million
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow